TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Pharmacorp Rx Inc. ( (TSE:PCRX) ) has shared an update.
PharmaCorp Rx Inc. has successfully completed the acquisition of three community pharmacies in Canada, expanding its national footprint with two pharmacies in Western Canada and one in Eastern Canada. This strategic move, aligned with its growth strategy and partnership with PharmaChoice Canada, aims to enhance the continuity of care for patients and preserve independent pharmacy legacies. The acquisitions, valued at a total of $8.7 million, were funded through a combination of cash, credit facilities, and the issuance of common shares, reflecting PharmaCorp’s commitment to active expansion in the pharmacy sector.
More about Pharmacorp Rx Inc.
PharmaCorp Rx Inc. operates in the pharmaceutical industry, focusing on acquiring and managing pharmacies under the PharmaChoice Canada banner. The company is committed to expanding its national presence by acquiring both PharmaChoice branded and independently owned pharmacies across Canada. PharmaCorp’s shares are traded on the TSX Venture Exchange under the symbol PCRX.
Average Trading Volume: 29,165
Technical Sentiment Signal: Hold
Current Market Cap: C$52.5M
For an in-depth examination of PCRX stock, go to TipRanks’ Overview page.